Showing results (21-30 of 119) with videos related to
Sort By:
Pageof 12
Biological & Pharmaceutical Bulletin|November 6, 2019
Dosing Time-Dependent Changes in the Anti-tumor Effect of xCT Inhibitor Erastin in Human Breast Cancer Xenograft MiceShoya Shiromizu, Tomoaki Yamauchi, Naoki Kusunose, et al.Cancer Research|May 9, 2018
Optimized Dosing Schedule Based on Circadian Dynamics of Mouse Breast Cancer Stem Cells Improves the Antitumor Effects of Aldehyde Dehydrogenase InhibitorNaoya Matsunaga, Takashi Ogino, Yukinori Hara, et al.Toxicology|December 21, 2010
Influence of CLOCK on cytotoxicity induced by diethylnitrosamine in mouse primary hepatocytesNaoya Matsunaga, Yumiko Kohno, Keisuke Kakimoto, et al.Journal of Structural Biology|January 6, 2026
High-Resolution single particle analysis using a scintillator camera XF416 on CRYOARM300II at 300 kVShinji Aramaki, Tomohito Tanihara, Yuya Yoshida, et al.Scientific Reports|September 1, 2017
Dysfunction of the circadian transcriptional factor CLOCK in mice resists chemical carcinogen-induced tumorigenesisKen-Ichi Hashikawa, Chiharu Katamune, Naoki Kusunose, et al.Life Sciences|September 9, 2008
Dosing schedule-dependent change in the disruptive effects of interferon-alpha on the circadian clock functionAkiko Shinohara, Satoru Koyanagi, Ahmed Mohsen Hamdan, et al.Cancer Research|November 22, 2011
Stress-regulated transcription factor ATF4 promotes neoplastic transformation by suppressing expression of the INK4a/ARF cell senescence factorsMichiko Horiguchi, Satoru Koyanagi, Akinori Okamoto, et al.Journal of Biochemistry|May 9, 2023
The scaffold protein PDZK1 governs diurnal localization of CNT2 on the plasma membrane in mouse intestinal epithelial cellsNour Jaballah, Yuya Tsurudome, Chiho Murakami, et al.Molecular Pharmacology|May 11, 2012
Role of activating transcription factor-4 in 24-hour rhythm of serotonin transporter expression in the mouse midbrainKentarou Ushijima, Satoru Koyanagi, Yuuki Sato, et al.The Journal of Biological Chemistry|June 26, 2022
RNA editing enzyme ADAR1 controls miR-381-3p-mediated expression of multidrug resistance protein MRP4 via regulation of circRNA in human renal cellsYuji Omata, Maseri Okawa, Mai Haraguchi, et al.Pageof 12